ZA916579B - Heterocyclic compounds and their preparation and use - Google Patents
Heterocyclic compounds and their preparation and useInfo
- Publication number
- ZA916579B ZA916579B ZA916579A ZA916579A ZA916579B ZA 916579 B ZA916579 B ZA 916579B ZA 916579 A ZA916579 A ZA 916579A ZA 916579 A ZA916579 A ZA 916579A ZA 916579 B ZA916579 B ZA 916579B
- Authority
- ZA
- South Africa
- Prior art keywords
- compounds
- preparation
- heterocyclic compounds
- forebrain
- hippocampus
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 150000004030 azacyclic compounds Chemical class 0.000 abstract 1
- 230000003920 cognitive function Effects 0.000 abstract 1
- 210000001320 hippocampus Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000004129 prosencephalon Anatomy 0.000 abstract 1
- 239000000021 stimulant Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Lubricants (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK198390A DK198390D0 (da) | 1990-08-21 | 1990-08-21 | Heterocykliske forbindelser, deres fremstilling og anvendelse |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA916579B true ZA916579B (en) | 1992-05-27 |
Family
ID=8109264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA916579A ZA916579B (en) | 1990-08-21 | 1991-08-20 | Heterocyclic compounds and their preparation and use |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5328924A (pt) |
| EP (1) | EP0544756B1 (pt) |
| JP (1) | JP3100158B2 (pt) |
| AT (1) | ATE159940T1 (pt) |
| AU (1) | AU660937B2 (pt) |
| CA (1) | CA2089767C (pt) |
| DE (1) | DE69128145T2 (pt) |
| DK (1) | DK198390D0 (pt) |
| ES (1) | ES2110997T3 (pt) |
| FI (1) | FI111640B (pt) |
| IE (1) | IE912958A1 (pt) |
| IL (1) | IL99145A (pt) |
| NO (1) | NO302414B1 (pt) |
| NZ (1) | NZ239451A (pt) |
| PT (1) | PT98734B (pt) |
| WO (1) | WO1992003430A1 (pt) |
| ZA (1) | ZA916579B (pt) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
| US5376668A (en) * | 1990-08-21 | 1994-12-27 | Novo Nordisk A/S | Heterocyclic compounds |
| DK198490D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
| US5753683A (en) * | 1993-08-19 | 1998-05-19 | Novo Nordisk A/S | Antipsychotic method |
| DK0734259T3 (da) * | 1993-08-19 | 2002-09-30 | Novo Nordisk As | Antipsykotisk fremgangsmåde |
| US5545638A (en) * | 1993-12-21 | 1996-08-13 | Novo Nordisk A/S | Method of treating gastrointestinal motility disorders |
| IL112024A (en) * | 1993-12-21 | 1999-07-14 | Novo Nordisk As | Pharmaceutical compositions comprising tetrahydropyridine derivatives substituted with oxadiazole or thiadiazole for treating gastrointestinal motility disorders |
| US5821371A (en) * | 1994-10-24 | 1998-10-13 | Eli Lilly And Comany | Heterocyclic compounds and their preparation and use |
| US5998404A (en) | 1994-10-24 | 1999-12-07 | Eli Lilly And Company | Heterocyclic compounds and their use |
| US5605908A (en) * | 1994-10-24 | 1997-02-25 | Eli Lilly And Company | Heterocyclic compounds and their use |
| US5726193A (en) * | 1994-10-31 | 1998-03-10 | Eli Lilly And Company | Method for treating anxiety |
| US5488056A (en) * | 1994-10-31 | 1996-01-30 | Eli Lilly And Company | Method for treating anxiety |
| US5574028A (en) * | 1994-10-31 | 1996-11-12 | Eli Lilly And Company | Method for treating anxiety |
| US5565475A (en) * | 1994-11-08 | 1996-10-15 | Muhlhauser; Mark A. | Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives |
| WO1997040042A1 (en) * | 1996-04-23 | 1997-10-30 | Eli Lilly And Company | Heterocyclic compounds |
| CA2252527A1 (en) * | 1996-04-23 | 1997-10-30 | Lone Jeppesen | Heterocyclic compounds |
| CA2250873A1 (en) * | 1996-04-23 | 1997-10-30 | Richard Lee Simon | Heterocyclic compounds |
| EP0910566B1 (en) * | 1996-04-24 | 2003-09-17 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
| US6090829A (en) * | 1996-08-01 | 2000-07-18 | Eli Lilly And Company | Method for treating excessive aggression |
| US6043258A (en) * | 1996-08-01 | 2000-03-28 | Eli Lilly And Company | Method for treating disruptive behavior disorders with xanomeline |
| US6117890A (en) * | 1996-08-01 | 2000-09-12 | Eli Lilly And Company | Method for treating bipolar disorder |
| US6034108A (en) * | 1997-07-28 | 2000-03-07 | Eli Lilly And Company | Method for treating mental retardation |
| US6206194B1 (en) | 1998-06-10 | 2001-03-27 | Motion Design, Inc. | Boxes with internal resilient elements and insert therefor |
| US6376675B2 (en) * | 1999-01-22 | 2002-04-23 | The University Of Toledo | Muscarinic receptor agonists |
| US6158589A (en) | 1999-09-23 | 2000-12-12 | Motion Design, Inc. | Boxes with internal resilient elements |
| US6311843B1 (en) | 1999-10-01 | 2001-11-06 | Motion Design, Inc. | Packaging boxes and components with internal resilient elements |
| US6302274B1 (en) | 1999-12-01 | 2001-10-16 | Sealed Air Corporation (Us) | Suspension and retention packaging structures and methods for forming same |
| US6490844B1 (en) | 2001-06-21 | 2002-12-10 | Emerging Technologies Trust | Film wrap packaging apparatus and method |
| EP2296471A4 (en) | 2008-05-15 | 2012-03-14 | Univ Toledo | MUSCARIC ACID AGONISTS AS COGNITIVE ENHANCERS |
| CA2786716A1 (en) * | 2010-01-11 | 2011-07-14 | Mithridion, Inc. | Compounds and compositions for cognition-enhancement, methods of making, and methods of treating |
| WO2012033956A1 (en) | 2010-09-08 | 2012-03-15 | Mithridion, Inc. | Cognition enhancing compounds and compositions, methods of making, and methods of treating |
| WO2012149524A1 (en) | 2011-04-29 | 2012-11-01 | The University Of Toledo | Muscarinic agonists as enhancers of working memory and cognitive flexibility |
| WO2021097427A1 (en) | 2019-11-15 | 2021-05-20 | Karuna Therapeutics, Inc. | Xanomeline derivatives and methods for treating neurological disorders |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
| GB8610432D0 (en) * | 1986-04-29 | 1986-06-04 | Akzo Nv | Amino-thiazole & oxazole derivatives |
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| GB8717446D0 (en) * | 1987-07-23 | 1987-08-26 | Merck Sharp & Dohme | Chemical compounds |
| NZ225999A (en) * | 1987-09-10 | 1992-04-28 | Merck Sharp & Dohme | Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions |
| IE63906B1 (en) * | 1987-11-13 | 1995-06-14 | Novo Nordisk As | Azabicyclic compounds and their preparation and use |
| EP0322182A3 (en) * | 1987-12-22 | 1992-01-02 | Beecham Group Plc | Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
| DK162892C (da) * | 1988-07-04 | 1992-05-11 | Novo Nordisk As | 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse |
| US5043345A (en) | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
| DE3905775A1 (de) | 1989-02-24 | 1990-08-30 | Kat Tec Ges Fuer Katalysatorte | Verfahren und vorrichtung zur reduzierung von schadstoffen eines verbrennungsverfahrens mit oxidations-wabenkatalysatoren und katalysatoren mit entschwefelungseigenschaften und abgasrueckfuehrung |
| DK198490D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
-
1990
- 1990-08-21 DK DK198390A patent/DK198390D0/da not_active Application Discontinuation
-
1991
- 1991-08-09 IL IL9914591A patent/IL99145A/en not_active IP Right Cessation
- 1991-08-14 US US07/745,033 patent/US5328924A/en not_active Expired - Fee Related
- 1991-08-19 NZ NZ239451A patent/NZ239451A/en unknown
- 1991-08-20 WO PCT/DK1991/000234 patent/WO1992003430A1/en not_active Ceased
- 1991-08-20 JP JP03513657A patent/JP3100158B2/ja not_active Expired - Fee Related
- 1991-08-20 AT AT91915249T patent/ATE159940T1/de not_active IP Right Cessation
- 1991-08-20 ZA ZA916579A patent/ZA916579B/xx unknown
- 1991-08-20 CA CA002089767A patent/CA2089767C/en not_active Expired - Fee Related
- 1991-08-20 AU AU84169/91A patent/AU660937B2/en not_active Ceased
- 1991-08-20 DE DE69128145T patent/DE69128145T2/de not_active Expired - Fee Related
- 1991-08-20 EP EP91915249A patent/EP0544756B1/en not_active Expired - Lifetime
- 1991-08-20 ES ES91915249T patent/ES2110997T3/es not_active Expired - Lifetime
- 1991-08-21 IE IE295891A patent/IE912958A1/en not_active IP Right Cessation
- 1991-08-21 PT PT98734A patent/PT98734B/pt not_active IP Right Cessation
-
1993
- 1993-02-19 NO NO930599A patent/NO302414B1/no unknown
- 1993-02-19 FI FI930745A patent/FI111640B/fi not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/472,351 patent/US5534528A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5328924A (en) | 1994-07-12 |
| FI930745L (fi) | 1993-03-30 |
| NO302414B1 (no) | 1998-03-02 |
| IE912958A1 (en) | 1992-02-26 |
| NO930599L (no) | 1993-04-19 |
| DE69128145T2 (de) | 1998-05-20 |
| CA2089767A1 (en) | 1992-02-22 |
| NZ239451A (en) | 1994-09-27 |
| JP3100158B2 (ja) | 2000-10-16 |
| AU660937B2 (en) | 1995-07-13 |
| PT98734B (pt) | 1999-01-29 |
| IL99145A0 (en) | 1992-07-15 |
| AU8416991A (en) | 1992-03-17 |
| EP0544756A1 (en) | 1993-06-09 |
| WO1992003430A1 (en) | 1992-03-05 |
| NO930599D0 (no) | 1993-02-19 |
| EP0544756B1 (en) | 1997-11-05 |
| DK198390D0 (da) | 1990-08-21 |
| DE69128145D1 (de) | 1997-12-11 |
| ES2110997T3 (es) | 1998-03-01 |
| ATE159940T1 (de) | 1997-11-15 |
| JPH06501682A (ja) | 1994-02-24 |
| US5534528A (en) | 1996-07-09 |
| CA2089767C (en) | 2005-05-03 |
| IL99145A (en) | 1996-10-31 |
| FI111640B (fi) | 2003-08-29 |
| PT98734A (pt) | 1992-08-31 |
| FI930745A0 (fi) | 1993-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA916579B (en) | Heterocyclic compounds and their preparation and use | |
| GR3029289T3 (en) | Heterocyclic compounds and their preparation and use | |
| ZA941542B (en) | Heterocyclic compounds their use and preparation | |
| ZA916580B (en) | Heterocyclic compounds and their preparation and use | |
| CA2010578A1 (en) | Piperidine compounds and their preparation and use | |
| FI954131A0 (fi) | Heterosykliset yhdisteet ja niiden valmistus ja käyttö | |
| ZA912122B (en) | Heterocyclic compounds and their preparation and use | |
| CA2157579A1 (en) | Heterocyclic compounds, their use and preparation |